CoChat

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

Open access

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Purpose Herein, we report the clinical outcomes of a multicenter study evaluating the role of SBRT in a cohort of patients affected by oligoprogressive castration-resistant prostate cancer (CRPC).Materials and methods This is a retrospective multicenter observational study including eleven centers. Inclusion criteria of the current study were: (a) Karnofsky performance status > 80, (b) histologically proven diagnosis of PC, (c) 1-5 oligoprogressive metastases, defined as progressive disease at bone or nodes levels (detected by means of choline PET/CT or CT plus bone scan) during ADT, (d) serum testosterone level under 50 ng/ml during ADT, (e) controlled primary tumor, (f) patients treated with SBRT with a dose of at least 5 Gy per fraction to a biologically effective dose (BED) of at least 80 Gy using an alpha-to-beta ratio of 3 Gy, (g) at least 6 months of follow-up post-SBRT.Results Eighty-six patients for a total of 117 lesions were treated with SBRT. The median follow-up was 30.7 months (range 4-91 months). The median new metastasis-free survival after SBRT was 12.3 months (95% CI 5.5-19.1 months). One- and two-year distant progression-free survival was 52.3% and 33.7%, respectively. Twenty-six out of 86 patients underwent a second course of SBRT due to further oligoprogressive disease: This resulted in a median systemic treatment-free survival of 21.8 months (95% CI 17.8-25.8 months). One-year systemic treatment-free survival was 72.1%.Conclusion SBRT appears to be a promising approach in oligoprogressive castration-resistant prostate cancer. Further investigations are warranted.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00345-019-02717-7

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 27 references

Cited by

See all 97

Metadata

Authors
Triggiani, L., Mazzola, R., Magrini, S. M., Ingrosso, G., Borghetti, P., Trippa, F., Lancia, A., Detti, B., Francolini, G., Matrone, F., Bortolus, R., Fanetti, G., Maranzano, E., Pasqualetti, F., Paiar, F., Bonù, M. L., Magli, A., Bruni, A., Mazzeo, E., Franzese, C., Scorsetti, M., Alongi, F., Jereczek-Fossa, B. A., Ost, P., & Buglione, M.
Affiliations
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
  • Ospedale Sacro Cuore Don Calabria (IT)
  • Policlinico Tor Vergata (IT)
  • Azienda Ospedaliera S.Maria (IT)
  • Azienda Ospedaliero-Universitaria Careggi (IT)
  • Centro di Riferimento Oncologico (IT)
  • Azienda Ospedaliera Universitaria Pisana (IT)
  • University of Udine (IT)
  • Azienda Ospedaliero-Universitaria di Modena (IT)
  • Humanitas University (IT)
  • Ghent University Hospital (BE)
Corresponding author
Mazzola, Rosario
Venue
World Journal of Urology
Published
2019-03-11
Volume
37
Issue
12
Pages
2631-2637
ISSN
  • 0724-4983 (ISSN-L)
  • 1433-8726
OpenAlex
W2921789984
Cited by
96
References
27
Citations by year
2026: 4 · 2025: 8 · 2024: 11 · 2023: 11 · 2022: 15 · 2021: 25 · 2020: 13 · 2019: 8
FWCI
11.21
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • www.springer.com/tdm (tdm)
Locations
  • World Journal of Urology (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Keywords
stereotactic body radiotherapy, metastasis-directed radiotherapy, bone metastasis, lymph node metastasis, androgen deprivation therapy
MeSH terms
Aged, Aged, 80 and over, Humans, Male, Middle Aged, Neoplasm Metastasis, Retrospective Studies, Radiosurgery, Prostatic Neoplasms, Castration-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. https://app.cochat.ai/papers/10.1007/s00345-019-02717-7
The paper
Triggiani, L., Mazzola, R., Magrini, S. M., Ingrosso, G., Borghetti, P., Trippa, F., Lancia, A., Detti, B., Francolini, G., Matrone, F., Bortolus, R., Fanetti, G., Maranzano, E., Pasqualetti, F., Paiar, F., Bonù, M. L., Magli, A., Bruni, A., Mazzeo, E., . . . Buglione, M. (2019). Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. World Journal of Urology. https://doi.org/10.1007/s00345-019-02717-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.